GLP-1 Pipeline Update.Regulatory Status: Semaglutide (Wegovy 2.4 mg SC) received FDA Accelerated Approval for noncirrhotic MASH with moderate to advanced fibrosis (F2-F3) in August 2025. Full approval is contingent on confirmatory trial results.
GLP-1 Messing With Your Mood? Blame Your Hormones. By Julie Vanek / . Tired woman dealing with hormonal changes in the bathroom mirror. GLP-1 and Hormones: How Appetite, PMS, and Mood Interact. You start the medication. Your appetite changes.
Read PIPELINE: GLP1 Plague by Paul Thomas for free. 3 chapters. Download PDF or read online.
What GLP-1 actually isHow your body makes more GLP-1Foods that stimulate GLP-1
Last updated 2025-06-16. 31 Likes, TikTok video from Simply Snyders (@gatorapril83): What I eat in a day on a GLP1 1805 calories, 165g protein Eating window 11:30am-6:30pm No gym today #wieiad #glp1community #glp1 #weightloss.
- Wegovy becomes first GLP-1 approved for MASH ($30B potential market), showing 62.9% steatohepatitis resolution in 72-week trials. - Oral 25mg Wegovy pill (13.6% weight loss) and dual-agonist CagriSema (15.7% weight loss) advance pipeline, targeting 2027 launch.
...and northern South America in the mantle reference frame: an update.
Abnehmspritzen wie Mounjaro und Ozempic verndern den Markt. Was GLP-1 Medikamente wirklich leisten und wo ihre Grenzen liegen.
